Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand-Reference-Cited by-同舟云学术

Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand

Published:2007-09 Issue:5 Volume:11 Page:402-406
ISSN:1201-9712
Container-title:International Journal of Infectious Diseases
language:en
Short-container-title:International Journal of Infectious Diseases

Author:

Koomanachai Pornpan,Tiengrim Surapee,Kiratisin Pattarachai,Thamlikitkul Visanu

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference16 articles.

1. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features;Bergogne-Berezin;Clin Microbiol Rev,1996

2. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare?;Livermore;Clin Infect Dis,2002

3. Surveillance of antibiotic resistance in European ICUs;Hamberger;J Hosp Infect,2001

4. Bacterial infections in hospitalized patients in Thailand in 1997 and 2000;Thamlikitkul;J Med Assoc Thai,2001

5. Epidemiology of Acinetobacter baumannii infections in Siriraj Hospital;Keerasuntonpong;Siriraj Med J,2006

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Therapeutic Approaches for Multidrug-Resistant and Extensively Drug-Resistant Acinetobacter baumannii Infections;Antibiotics;2024-03-15

2. Dexmedetomidine may reduce the risk of acute kidney injury development in critically ill patients during colistin therapy;Journal of Infection and Chemotherapy;2023-07

3. Colistin Monotherapy versus Colistin plus Sitafloxacin for Therapy of Carbapenem-Resistant Acinetobacter baumannii Infections: A Preliminary Study;Antibiotics;2022-11-26

4. A Randomized Controlled Trial of Colistin Combined with Sulbactam: 9 g per Day versus 12 g per Day in the Treatment of Extensively Drug-Resistant Acinetobacter baumannii Pneumonia: An Interim Analysis;Antibiotics;2022-08-17

5. Characteristics, Influencing Factors, Predictive Scoring System, and Outcomes of the Patients with Nephrotoxicity Associated with Administration of Intravenous Colistin;Antibiotics;2021-12-21